Human immunodeficiency virus infection and levels of dehydroepiandrosterone sulfate in plasma among Indians

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 9, 2005, Pages 1117-1118

  Kandathil, A J ^a   Kannangai, R ^a   David, S ^a   Selvakumar, R ^a   Job, V ^a   Abraham, O C ^a   Sridharan, G ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PRASTERONE SULFATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTEROID BLOOD LEVEL; CYTOKINE PRODUCTION; DISEASE COURSE; ECONOMIC ASPECT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIAN; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RADIOIMMUNOASSAY; VIRUS LOAD;

ADULT; BIOLOGICAL MARKERS; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HIV INFECTIONS; HUMANS; INDIA; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; VIRAL LOAD;

EID: 24944459732     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.9.1117-1118.2005     Document Type: Article

References (10)

1. Christeff, N., E. A. Nunez, and M. L. Gougeon. 2000. Changes in cortisol/DHEA ratio in HIV-infected men are related to immunological and metabolic perturbations leading to malnutrition and lipodystrophy. Ann. N. Y. Acad. Sci. 917:962-970.
2. Christeff, N., N. Gherbi, O. Mammes, M. T. Dalle, S. Gharakhanian, O. Lortholary, J. C. Mechior, and E. A. Nunez. 1997. Serum cortisol and DHEA concentrations during HIV infection. Psychoneuroendocrinology 22(Suppl. 1):S11-S18.
3. Clerici, M., and G. M. Shearer. 1993. A TH1 to TH2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14:107-111.
4. Clerici, M., M. Bevilacqua, T. Vago, M. L. Villa, G. M. Shearer, and G. Norbiato. 1994. An immunoendocrinological hypothesis of HIV infection. Lancet 343:1552-1553.
5. Ferrando, S. J., J. G. Rabkin, and L. Poretsky. 1999. Dehydroepiandrosterone sulfate (DHEAS) and testosterone: relation to HIV illness stage and progression over one year. J. Acquir. Immune Defic. Syndr. 22:146-154.
6. Loria, R. M., T. H. Inge, S. S. Cook, A. K. Szakal, and W. Regelson. 1988. Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA). J. Med. Virol. 26:301-314.
7. Mauboussin, J. M., A. Mahamat, H. Peyriere, I. Rouanet, P. Fabbro-Peray, J. P. Daures, and D. Vincent. 2004. Low plasma levels of dehydroepiandrosterone sulphate in HIV-positive patients coinfected with hepatitis C virus. HIV Med. 5:151-157.
8. Osmanov, S., C. Pattou, N. Walker, B. Schwardlander, J. Esparza and the WHO-UNAIDS Network for HIV Isolation and Characterization. 2002. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J. Acquir. Immune Defic. Syndr. 29:184-190.
9. Ramalingam, S., R. Kannangai, T. S. Vijayakumar, D. Mathai, O. C. Abraham, S. Subramanian, P. Rupali, M. V. Jesudason, and G. Sridharan. 2005. Subtype & cytokine profiles of HIV infected individuals from south India. Indian J. Med. Res. 121:226-234.
10. Schifitto, G., M. P. McDermott, T. Evans, T. Fitzgerald, J. Schwimmer, L. Demeter, and K. Kieburtz. 2000. Autonomic performance and dehydroepiandrosterone sulfate levels in HIV-1-infected individuals: relationship to TH1 and TH2 cytokine profile. Arch. Neurol. 57:1027-1032.